GlassScriptPhysician profile
Amanda Gaddis
NPI 1790188142
$1,742.35
in general payments reported to CMS, 2019-2025
16 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $810 · 2022: $94.48 · 2023: $394 · 2024: $171 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $884.76 | 2021-2025 | Pristine, Lutonix Drug Coated Balloon, Denali Vena Cava Filter |
| W. L. Gore & Associates, INC. | $259.21 | 2021-2023 | Gore Propaten Vascular Graft, Gore Acuseal Vascular Graft |
| Janssen Pharmaceuticals, INC | $216.84 | 2021-2022 | |
| Allergan, INC. | $91.58 | 2021 | |
| Amgen INC. | $63.48 | 2021-2025 | Tavneos, Evenity |
| Daiichi Sankyo INC. | $31.95 | 2021 | |
| Silk Road Medical, INC. | $31.75 | 2021-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Astrazeneca Pharmaceuticals LP | $24.50 | 2021 | |
| Calliditas Therapeutics US INC. | $22.66 | 2025 | Tarpeyo |
| Davol INC. | $18.92 | 2021 | |
| Convatec INC. | $18.54 | 2023 | |
| Surmodics, INC. | $18.50 | 2025 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Pfizer INC. | $16.41 | 2021 | |
| Abbvie INC. | $14.79 | 2022 | |
| Akebia Therapeutics INC | $14.59 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $13.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Gaddis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.